Rani Therapeutics Holdings, Inc. - Class A Common Stock (RANI)
2.5550
-0.2950 (-10.35%)
NASDAQ · Last Trade: Oct 22nd, 2:21 PM EDT
Detailed Quote
Previous Close | 2.850 |
---|---|
Open | 3.560 |
Bid | 2.550 |
Ask | 2.560 |
Day's Range | 2.260 - 3.870 |
52 Week Range | 0.3870 - 3.320 |
Volume | 58,478,944 |
Market Cap | 64.49M |
PE Ratio (TTM) | -2.808 |
EPS (TTM) | -0.9 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 36,129,043 |
Chart
About Rani Therapeutics Holdings, Inc. - Class A Common Stock (RANI)
Rani Therapeutics Holdings Inc. is a biopharmaceutical company focused on developing innovative oral therapies for the delivery of biologics, such as peptides and proteins, which traditionally require injection for administration. The company’s proprietary RaniPill platform utilizes a novel approach to encapsulate and deliver these treatments orally, aiming to enhance patient compliance and accessibility in the administration of complex medications. By combining advanced engineering with pharmaceutical expertise, Rani Therapeutics is exploring solutions that could revolutionize the landscape of therapeutic delivery, making it more patient-friendly. Read More
News & Press Releases
Via Benzinga · October 22, 2025
Let's explore the current happenings on the US markets on Wednesday. Below, you'll find the stocks exhibiting unusual volume in today's session.
Via Chartmill · October 22, 2025
Via Benzinga · October 22, 2025
Stay up-to-date with the latest market trends one hour before the close of the markets on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · October 21, 2025
Let's dive into the action on the US markets on Tuesday. Here are the most active stocks that are driving the market today.
Via Chartmill · October 21, 2025
Via Benzinga · October 21, 2025
Which stocks have an unusual volume on Tuesday?
Via Chartmill · October 21, 2025
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Via Chartmill · October 21, 2025
Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands and major indexes reach record levels.
Via Benzinga · October 21, 2025
Let's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · October 20, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.
Via Chartmill · October 20, 2025
Via Benzinga · October 20, 2025
Let's dive into the action on the US markets on Monday. Here are the most active stocks that are driving the market today.
Via Chartmill · October 20, 2025
In today's session, these stocks are experiencing unusual volume.
Via Chartmill · October 20, 2025
Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · October 20, 2025
As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · October 20, 2025
Via Benzinga · October 20, 2025
Via Benzinga · October 20, 2025
Curious about the most active stocks on Friday? Find out which stocks are dominating the market action!
Via Chartmill · October 17, 2025
Via Benzinga · October 17, 2025
Via Benzinga · October 17, 2025
Via Benzinga · October 17, 2025
Rani Therapeutics (NASDAQ: RANI) stock surged on licensing collaboration with Chugai and $60.3M private placement. RANI up 191.99% at $1.375.
Via Benzinga · October 17, 2025
Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · October 17, 2025
Via Benzinga · October 17, 2025